Hai cercato la traduzione di liraglutide da Inglese a Estone

liraglutide
liraglutiid

saxenda liraglutide
saxenda liraglutiid

liraglutide 1.2 mg
liraglutiid 1,2 mg

randomised liraglutide + metformin
randomiseeritud liraglutiid + metformiin

the active substance is liraglutide.
toimeaine on liraglutiid.

xultophy insulin degludec / liraglutide
xultophy degludekinsuliin/liraglutiid

1 ml contains 6 mg of liraglutide.
1 ml sisaldab 6 mg liraglutiidi.

victoza 6 mg/ml injection liraglutide
victoza 6 mg/ml süstelahus

one pre­filled pen contains 18 mg liraglutide
Üks pensüstel sisaldab 18 mg liraglutiidi.

liraglutide exposure increased proportionally with dose.
liraglutiidi ekspositsioon kasvas proportsionaalselt annusega.

saxenda contains the active substance liraglutide.
saxenda sisaldab toimeainena liraglutiidi.

the results were similar for xultophy and liraglutide.
xultophy ja liraglutiidi tulemused olid sarnased.

1 ml of solution contains 6 mg of liraglutide*.
1 ml lahust sisaldab 6 mg liraglutiidi*.

a drop of liraglutide should appear at the needle tip.
liraglutiidi tilk peab ilmuma nõela otsa.

substances added to victoza may cause degradation of liraglutide.
victoza’le lisatud ained võivad põhjustada liraglutiidi lagunemist.

after that, you may see a drop liraglutide at the needle tip.
pärast seda võite nõela otsas näha liraglutiidi tilka.

# p < 0.05 dulaglutide treatment group compared to liraglutide.
# p < 0,05, ## p < 0,001 dulaglutiidi ravigrupp võrreldes glargiin-insuliiniga

antibody formation has not been associated with reduced efficacy of liraglutide.
antikehade teket ei ole seostatud liraglutiidi efektiivsuse langusega.

clinical trial data - levemir add-on to liraglutide+metformin
kliiniliste uuringute andmed – levemir lisatuna liraglutiidile+metformiinile

absolute bioavailability of liraglutide following subcutaneous administration is approximately 55%.
liraglutiidi absoluutne biosaadavus pärast nahaalust manustamist on umbes 55%.